00:00
Evotec, Dr. Cord Dohrmann, Evotec - Partner of choice for oncology drug discovery.
00:08
, Evotec at a glance
00:15
R&D;, Profitable, revenue, growth, alliances, pipeline, Phase III, Phase II and Phase I , Leader in high quality drug discovery solutions
01:18
scientists, location, Global reach for global projects - approx. 600 scientists
02:38
alliances, biology, Metabolics, Oncology, CNS, Immunology , Drug discovery alliances & more
03:08
value chain, cell types, chemistry, Best-in-class platforms yield superior productivity
04:03
pipeline, risk, Indication, Commercials
, Deep clinical pipeline without financial risk
04:46
, Experience and current oncology partners
04:50
oncology platform, Targets, Tumor metabolism,
compounds, Productive oncology platform
05:36
oncology alliances, Drug discovery partners,
Biomarker development
, Current oncology alliances
07:20
, Examples of cancer alliances
07:25
Boehringer Ingelheim-Alliance, oncology, Milestones , Boehringer Ingelheim-Alliance Focus on cancer
08:10
Biomarkers , Response Prediction, Personalized Medicine,
chemotherapy, Targeted Therapies
, The future paradigm in oncology
08:50
Phospho-signatures as biomarkers,
proteins, pathways, phosphorylation , Phospho-signatures as biomarkers
09:40
oncology, biomarker development, PhosphoScout, quantification of cellular phosphorylation
, Roche oncology alliance
10:06
, Opportunities with Evotec
10:10
Opportunities, Drug Design platforms, Mesoscale, acetylomics, Phenotypic, Epigenetic , Leveraging Evotec expertise in oncology
10:38
, Evotec - contact info